In 2023, the FDA deemed 19 peptides too unsafe to be dispensed by compounding pharmacies. Now, under RFK Jr., the agency is poised to reverse itself despite the fact that few FDA Peptide Reclassification 2026: What It Means for Providers RFK Jr.'s peptide push could unleash risky drugs STAT First Opinion The Peptide Moment: How FDA's Regulatory Reversal Creates Risk and Opportunity for Venture Capital and Private Equity Guidepost Solutions BPC 157 Dosage: A Complete Guide Nulevel Wellness Medspa